Acadian Asset Management LLC Abb Vie Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 117,639 shares of ABBV stock, worth $20.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

117,639

Previous 249,741 52.9%

Holding current value

$20.2 Million

Previous $42.8 Million 45.77%

% of portfolio

0.07%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $21.6 Million - $26.3 Million	-132,102 Reduced 52.9%	117,639 $23.2 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $8.89 Million - $10.4 Million	-57,463 Reduced 18.71%	249,741 $42.8 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $7.26 Million - $8.27 Million	-45,413 Reduced 12.88%	307,204 $55.9 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $320,057 - $360,460	-2,326 Reduced 0.66%	352,617 $54.6 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $6.66 Million - $7.71 Million	49,880 Added 16.35%	354,943 $52.9 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $14.3 Million - $17.9 Million	-108,255 Reduced 26.19%	305,063 $41.1 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $18.1 Million - $20.9 Million	125,363 Added 43.54%	413,318 $65.9 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1.33 Million - $1.59 Million	-9,599 Reduced 3.23%	287,955 $46.5 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $24.1 Million - $27.6 Million	-179,498 Reduced 37.63%	297,554 $39.9 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $24.1 Million - $27.6 Million	-179,498 Reduced 37.63%	297,554 $39.9 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $6.82 Million - $8.67 Million	49,572 Added 11.6%	477,052 $73.1 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $56.1 Million - $69.6 Million	424,762 Added 15627.74%	427,480 $69.3 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.25 Million - $1.42 Million	-11,721 Reduced 81.18%	2,718 $293,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $126,663 - $149,077	-1,642 Reduced 10.21%	14,439 $1.16 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $5,527 - $6,816	-71 Reduced 0.44%	16,081 $1.48 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $291,358 - $323,898	-3,277 Reduced 16.87%	16,152 $1.53 Million
Q2 2018 Jul 24, 2018	SELL	$89.78 - $106.23 $6,823 - $8,073	-76 Reduced 0.39%	19,429 $1.8 Million
Q1 2018 Apr 12, 2018	SELL	$92.01 - $123.21 $2.21 Million - $2.97 Million	-24,071 Reduced 55.24%	19,505 $1.85 Million
Q4 2017 Jan 18, 2018	BUY	$89.56 - $98.21 $2.6 Million - $2.85 Million	29,038 Added 199.74%	43,576 $4.21 Million
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $1.02 Million - $1.3 Million	14,538	14,538 $1.29 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Abb Vie Inc. Transaction History